Discover How Laminine™ Can Improve Your Health... Watch The Video Above!
Laminine™ Will Help Anyone. The Benefits, When Taken Regularly May Include...
Make 2017... the Year You Improve Your Health!
Join Thousands in 42 Countries
(shown at the bottom of this page) Who Are Already Seeing Amazing Health Benefits from
Regular Use of Laminine™ & Laminine™ Omega Plus!
"The Happy Pill"
Laminine™ is a
Natural, Synergistic SuperFood
that contains 22 amino
acids, trace minerals, vitamins and Fibroblast Growth Factor (FGF)
The perfect combination of life-giving sustenance sourced from land, sea
Its source is from the "Miracle of
Clinical Studies have been conducted which showed Laminine's™ positive effects on Physical, Mental, Emotional Strengths and Overall Health. Laminine™ is an all Natural Product
CLICK HERE To Join My Group & Order (Wholesale) & Choose the "Laminine™ Activation Pack"
A boiling pot of global conditions, like ubiquitous travel and the growing populations of developing cities, have led to an outbreak of pandemics like Ebola, Zika, SARs, and even the flu over the past decade.
But while the global health industry and national governments and regulators have made a lot of progress, there’s still much more that these groups can do together to better plan, fund, and organize the battle against emerging pandemics, said a group of experts at Fortune’s Brainstorm Health conference in San Diego, Calif. on Tuesday night.
Once an outbreak occurs, the response is all about speed, said Bruce Gellin, director of the U.S. National Vaccine Program Office.
But the focus on a rapid response belies the need to invest much more in preventing pandemics. “We need a new model, because the one we have now isn’t working,” said Gellin.
Companies and regulators need to better understand the evolution of viruses, and which parts of the viruses are not as variable, said Gellin. The work on flu vaccines, for example, historically began with eggs, and “we’re still making them much the same way,” he said.
Michael Osterholm, director for the Center for Infectious Disease Research and Policy at the University of Minnesota, said there needs to be better systems in place to measure and monitor safety in pandemics. “That’s where big data can be great,” he said.
There also needs to be better anticipation of where and how pandemics occur, said Osterholm. “We can’t go from crisis to crisis,” he said. “We could have anticipated Zika.”
Moncef Slaoui, chairman of vaccines for GlaxoSmithKline GSK -0.40% , said the company’s experience building a vaccine for Ebola was troubling. Slaoui said that GlaxoSmithKline dedicated all of its vaccine project resources to working on one for Ebola starting in August 2014, before bringing a vaccine to trials by February 2016.
While that’s much faster than the traditional process, the world had moved on to Zika and other pressing pandemics by the time the vaccine made it to trials. The process left GlaxoSmithKline vulnerable to significant financial exposure, with a half-baked vaccine and enormous expenses, said Slaoui.
The pharmaceutical giant exec said there needs to be a better way for companies to get involved working on how to “save the world” in these pressing situations. Right now, building vaccines against pandemics is like getting car insurance while you’re already in a car accident, said Slaoui.
This article originally appeared on Fortune.com
After Clicking on One of the Links Below, Just CLICK the "Click Here to Agree and Continue" Button in the "Informed Consent and Participation Agreement" Form... to Begin Your Own Personal Q & A Session on How Laminine and Laminine Omega +++ Can Help You Achieve PERFECT Health.